Budd–Chiari syndrome is one of those Step 1 “don’t-miss” hepatic vascular disorders because the mechanism is straightforward, the risk factors are highly testable, and the clinical picture can look like other causes of portal hypertension unless you know the key clues. If you can connect hepatic venous outflow obstruction → congestive hepatopathy → portal HTN + liver injury, you’ll get most questions right.
Definition (what Budd–Chiari is)
Budd–Chiari syndrome (BCS) = obstruction of hepatic venous outflow, usually due to thrombosis of the hepatic veins (and sometimes the IVC near where hepatic veins drain).
- Think: blood can’t leave the liver → hepatic congestion → hepatomegaly, pain, ascites, portal hypertension
- High-yield contrast:
- Portal vein thrombosis = problem before the liver (prehepatic portal HTN)
- Cirrhosis = problem within the liver (intrahepatic portal HTN)
- Budd–Chiari = problem after the liver (posthepatic portal HTN)
First Aid cross-reference: Typically found under Portal hypertension, Budd–Chiari syndrome, and hypercoagulable states (heme/onc). (Check GI “liver pathology” + heme thrombophilias sections in your edition.)
Pathophysiology (the “why it happens” chain)
Core mechanism
- Hepatic vein outflow obstruction (most often thrombotic)
- Sinusoidal congestion and increased hepatic venous pressure
- Hepatomegaly (congested, tender liver)
- Increased hydrostatic pressure → ascites
- Reduced perfusion + congestion → ischemic hepatocyte injury
- Over time: fibrosis/cirrhosis and complications of portal hypertension
Histology (what to visualize)
- Congestive hepatopathy: classically centrilobular (zone 3) congestion and necrosis
- “Nutmeg liver” is the classic gross description for chronic venous congestion (commonly taught with right-sided heart failure, but the congestion concept maps well here).
Acute vs chronic
- Acute BCS: abrupt thrombosis → severe RUQ pain, tender hepatomegaly, rapidly developing ascites, marked LFT elevation possible
- Chronic BCS: slower obstruction → progressive portal HTN, ascites, splenomegaly, varices; cirrhosis can develop
Clinical presentation (what you see on exams)
Classic triad (very testable)
Abdominal pain (RUQ) + ascites + hepatomegaly
Other common findings:
- Jaundice (variable; more likely if severe/acute)
- Portal hypertension signs: splenomegaly, variceal bleeding
- Dilated abdominal wall veins (collaterals), edema
- Hepatic encephalopathy in severe cases / liver failure
High-yield differentiation: Budd–Chiari vs congestive hepatopathy from right HF
Both can cause hepatic congestion and “nutmeg” changes, but:
- Budd–Chiari: hepatic vein thrombosis/outflow obstruction; often hypercoagulable risk factors
- Right-sided HF / constrictive pericarditis: systemic venous congestion signs (JVD, peripheral edema, hepatojugular reflux); may still develop ascites and hepatomegaly
HY associations (memorize these)
Budd–Chiari is strongly linked to hypercoagulable states.
Common Step associations
- Polycythemia vera (often via JAK2 mutation)
- Paroxysmal nocturnal hemoglobinuria (PNH)
- Pregnancy / postpartum
- Oral contraceptive use / estrogen therapy
- Antiphospholipid syndrome
- Inherited thrombophilias:
- Factor V Leiden
- Prothrombin gene mutation
- Protein C deficiency
- Protein S deficiency
- Antithrombin deficiency
- Malignancy (hypercoagulability or direct invasion/compression)
- Especially hepatocellular carcinoma or other intra-abdominal tumors
Quick memory anchor
If a stem screams “hypercoagulable” + “painful hepatomegaly and ascites,” think Budd–Chiari.
First Aid cross-reference: Hypercoagulable states list (heme) + portal HTN vascular causes (GI).
Diagnosis (what tests and imaging show)
Labs (supportive, not definitive)
- Elevated AST/ALT (often in acute cases)
- Elevated bilirubin (variable)
- Low albumin, prolonged PT/INR if hepatic synthetic function declines
- Workup should include evaluation for thrombophilia (especially if no obvious provoking factor)
Imaging (the key)
Doppler ultrasound is typically the first-line test:
- Reduced/absent flow in hepatic veins
- Thrombus may be visualized
- Collateral venous flow may be seen
CT or MRI with contrast can further characterize:
- Hepatic vein/IVC obstruction
- Patchy enhancement patterns, caudate lobe hypertrophy (classic teaching: caudate lobe drains directly into IVC and may be relatively spared/hypertrophied)
Hepatic venography:
- Considered the gold standard in some contexts; used when diagnosis is uncertain or to plan interventions.
Exam-style phrasing to recognize
- “Absent hepatic vein flow on Doppler”
- “Hypercoagulable patient with ascites and tender hepatomegaly”
- “Caudate lobe enlargement with hepatic venous outflow obstruction”
Treatment (Step-level approach)
Management depends on acuity and severity, but Step questions usually want the big moves:
1) Anticoagulation (cornerstone if thrombotic)
- Start therapeutic anticoagulation unless contraindicated
- Treat underlying hypercoagulable condition when possible
2) Restore outflow when needed
- Thrombolysis and/or angioplasty/stenting in select acute cases
- TIPS (transjugular intrahepatic portosystemic shunt) to decompress portal system when refractory ascites/portal HTN complications
3) Supportive care
- Sodium restriction + diuretics for ascites (e.g., spironolactone ± loop diuretic)
- Manage complications: variceal bleeding prophylaxis/treatment, encephalopathy management if present
4) Liver transplant (definitive for end-stage or fulminant failure)
- Indicated if progressive liver failure or refractory disease despite other interventions
High-yield test framing: If you see BCS with significant portal HTN complications despite anticoagulation, TIPS is a classic next step; transplant is the endpoint for irreversible failure.
High-yield comparisons (common traps)
Budd–Chiari vs Portal vein thrombosis
| Feature | Budd–Chiari | Portal vein thrombosis |
|---|---|---|
| Obstruction location | Hepatic veins/IVC (posthepatic) | Portal vein (prehepatic) |
| Key associations | Hypercoagulable states (PV, PNH, OCPs, pregnancy) | Cirrhosis, malignancy, infection, hypercoagulability |
| Classic findings | RUQ pain + hepatomegaly + ascites | Portal HTN signs; pain variable; hepatomegaly less classic |
| Imaging clue | Absent hepatic venous flow on Doppler | Portal vein clot / cavernous transformation |
Budd–Chiari vs Cirrhosis (portal HTN)
| Feature | Budd–Chiari | Cirrhosis |
|---|---|---|
| Onset | Often acute/subacute | Usually chronic/gradual |
| Liver size | Hepatomegaly common early | Small, nodular liver in advanced disease |
| Risk factors | Hypercoagulability | EtOH, viral hepatitis, NAFLD, etc. |
| Pain | RUQ pain common | Often painless until decompensation |
USMLE-style “stem triggers” (what to highlight as you read)
If you see:
- Young woman on OCPs with RUQ pain + ascites
- Polycythemia vera patient with abdominal pain and hepatomegaly
- PNH with new ascites and abnormal LFTs
- Doppler showing no hepatic vein flow …then the answer is very likely Budd–Chiari syndrome.
Rapid review (what to memorize)
- Definition: hepatic venous outflow obstruction (hepatic veins/IVC)
- Triad: RUQ pain + hepatomegaly + ascites
- Associations: PV (JAK2), PNH, pregnancy, OCPs, APS, Factor V Leiden, malignancy
- Diagnosis: Doppler ultrasound
- Treatment: anticoagulation, treat cause; TIPS if refractory; transplant if failure